These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16314657)

  • 21. Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.
    Ellis MJ; Coop A; Singh B; Tao Y; Llombart-Cussac A; Jänicke F; Mauriac L; Quebe-Fehling E; Chaudri-Ross HA; Evans DB; Miller WR
    Cancer Res; 2003 Oct; 63(19):6523-31. PubMed ID: 14559846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Status of estrogen and progesterone receptors in various phases of the menstrual cycle in breast cancer.
    Vasei M; Azarpira N; Talei A
    Arch Iran Med; 2006 Jul; 9(3):250-3. PubMed ID: 16859061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases.
    Desouki MM; Atta IS; Wolff DJ; Self SE
    Turk Patoloji Derg; 2016; 32(3):178-85. PubMed ID: 27562392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
    Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP
    Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of neoadjuvant chemotherapy on estrogen and progesterone receptors and HER-2 in breast cancer].
    Zhao J; Wu YL; Wang YD; Zhao GR; Wang J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1437-9. PubMed ID: 15604081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
    Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
    Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
    Badowska-Kozakiewicz A; Sobol M; Patera J
    Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
    Ferrero-Poüs M; Hacène K; Bouchet C; Le Doussal V; Tubiana-Hulin M; Spyratos F
    Clin Cancer Res; 2000 Dec; 6(12):4745-54. PubMed ID: 11156229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer.
    Roepman P; Horlings HM; Krijgsman O; Kok M; Bueno-de-Mesquita JM; Bender R; Linn SC; Glas AM; van de Vijver MJ
    Clin Cancer Res; 2009 Nov; 15(22):7003-11. PubMed ID: 19887485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of human epidermal growth factor receptor 2 (HER-2/neu) receptor status with hormone receptors Oestrogen Receptor, Progesterone Receptor status and other prognostic markers in breast cancer: an experience at tertiary care hospital in Karachi.
    Mujtaba S; Haroon S; Faridi N; Lodhi FR
    J Pak Med Assoc; 2013 Jul; 63(7):854-8. PubMed ID: 23901708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.
    Kim C; Lee J; Lee W; Kim A
    Int J Clin Exp Pathol; 2015; 8(11):15184-90. PubMed ID: 26823864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls.
    Moriki T; Takahashi T; Ueta S; Mitani M; Ichien M
    Diagn Cytopathol; 2004 Apr; 30(4):251-6. PubMed ID: 15048960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of hormonal receptors and human epidermal growth factor receptor 2 in Mexican female patients with breast cancer].
    Pérez G; Aranda C; Olivares IM; García JR
    Med Clin (Barc); 2014 Sep; 143(5):231-2. PubMed ID: 24183125
    [No Abstract]   [Full Text] [Related]  

  • 35. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.
    Bouras T; Southey MC; Venter DJ
    Cancer Res; 2001 Feb; 61(3):903-7. PubMed ID: 11221879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer.
    Horiguchi J; Iino Y; Takei H; Yokoe T; Ishida T; Morishita Y
    Oncology; 1994; 51(1):47-51. PubMed ID: 7903441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma.
    East EG; Pang JC; Kidwell KM; Jorns JM
    Am J Clin Pathol; 2015 Dec; 144(6):952-9. PubMed ID: 26573003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of progesterone receptor expression in a population-based analysis.
    Caldarella A; Barchielli A
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2505-2509. PubMed ID: 28889189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients.
    Uy GB; Laudico AV; Carnate JM; Lim FG; Fernandez AM; Rivera RR; Mapua CA; Love RR
    Clin Breast Cancer; 2010 Apr; 10(2):154-9. PubMed ID: 20299318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors that influence the incidence of microscopic carcinoma in frozen and preserved specimens from patients with breast carcinoma after breast-conserving surgery.
    Kim R; Osaki A; Kaneko M; Inai K; Toge T
    Oncol Rep; 2003; 10(5):1321-8. PubMed ID: 12883701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.